2017
DOI: 10.1056/nejmra1514009
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms, Pathophysiology, and Management of Obesity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
1,043
2
56

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 1,382 publications
(1,108 citation statements)
references
References 72 publications
7
1,043
2
56
Order By: Relevance
“…1 , 42 Any early risk-prediction marker that identifies these populations would be helpful to prevent the whole spectrum of both medical conditions. IR is a biochemical abnormality associated to these since the first stages in its pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…1 , 42 Any early risk-prediction marker that identifies these populations would be helpful to prevent the whole spectrum of both medical conditions. IR is a biochemical abnormality associated to these since the first stages in its pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…O reganho de peso na CB é definido como o aumento ponderal que pode ocorrer a partir do menor peso pós-cirúr-gico 5 . A perda de peso ocorre de forma rápida no pós-operatório imediato, em função dos mecanismos de proteção metabólico e adaptação do paciente à restrição gástrica e ao aumento inicial da saciedade 5 .…”
Section: Introductionunclassified
“…A perda de peso ocorre de forma rápida no pós-operatório imediato, em função dos mecanismos de proteção metabólico e adaptação do paciente à restrição gástrica e ao aumento inicial da saciedade 5 . A diminuição ponderal, no entanto, tende a se estabilizar ao longo dos primeiros 12 meses 4 .…”
Section: Introductionunclassified
See 1 more Smart Citation
“…On the one hand, extremely obese patients are at increased cardiovascular risk over their lifespan as a result of chronic metabolic disease. 2 They are also less likely to exercise or to be functionally active, and as such, may not manifest cardiovascular symptoms until the later stages of disease, possibly warranting a high index of suspicion for evaluation. On the other hand, extremely obese patients are also less likely to undergo an evaluation of sufficient diagnostic quality, no matter the imaging modality utilized.…”
mentioning
confidence: 99%